Emergent Biosolutions reported $329M in Sales Revenues for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Acadia Pharmaceuticals ACAD:US $ 131.61M 16.39M
Akebia Therapeutics AKBA:US $ 48.76M 4.16M
ALKERMES ALKS:US $ 294.14M 9.58M
Alnylam Pharmaceuticals ALNY:US $ 187.63M 32.92M
Amarin AMRN:US $ 142.04M 12.45M
Ani Pharmaceuticals ANIP:US $ 52.06M 3.44M
Biomarin Pharmaceutical BMRN:US $ 408.74M 92.95M
Chimerix CMRX:US $ 0.11M 0.28M
Coherus Biosciences CHRS:US $ 82.5M 5.14M
Emergent Biosolutions EBS:US $ 329M 68.5M
Exact Sciences EXAS:US $ 456.38M 21.56M
Exelixis EXEL:US $ 328.42M 56.75M
Flexion Therapeutics FLXN:US $ 21.33M 6.85M
Glaxosmithkline GSK:US $ 9077M 985M
Heron Therapeutics HRTX:US $ 23.23M 0.79M
Immunogen IMGN:US $ 9.21M 7.74M
Intercept Pharmaceuticals ICPT:US $ 92.83M 3.75M
IONIS PHARMACEUT IONS:US $ 133M 7.25M
Ironwood Pharmaceuticals IRWD:US $ 103.75M 0.28M
JAZZ PHA JAZZ:US $ 838.12M 86.3M
Lexicon Pharmaceuticals LXRX:US $ 0.02M 0.21M
Lonza Group LONN:SW 2.54B 1.11B
Merk MRK:US $ 13154M 1752M
Moderna Inc MRNA:US 4.97B 615M
Myriad Genetics MYGN:US $ 167.3M 22.1M
Nektar Therapeutics NKTR:US $ 24.92M 3.41M
Neurocrine Biosciences NBIX:US $ 296M 7.1M
Opko Health OPK:US $ 385.81M 56.6M
Pacira Pharmaceuticals PCRX:US $ 127.72M 7.87M
Pfizer PFE:US $ 24094M 5117M
Ptc Therapeutics PTCT:US $ 138.74M 22.07M
Sarepta Therapeutics SRPT:US $ 189.41M 25.32M
Seattle Genetics SGEN:US $ 424.06M 35.58M
Teva Pharmaceutical Industries TEVA:US $ 3887M 23M
United Therapeutics UTHR:US $ 444.7M 1.8M
Vanda Pharmaceuticals VNDA:US $ 70.1M 2.2M
Xoma XOMA:US $ 940K 39K